Faculty Opinions recommendation of Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.

Peptic Ulcers ◽

Inflammatory Drug ◽

Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2012.05133.x ◽

2012 ◽

Vol 36 (2) ◽

pp. 115-125 ◽

Cited By ~ 13

Author(s):

K. Sugano ◽

Y. Kinoshita ◽

H. Miwa ◽

T. Takeuchi ◽

Keyword(s):

Clinical Trial ◽

Japanese Patients ◽

Peptic Ulcers ◽

Inflammatory Drug ◽

Faculty Opinions recommendation of Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548132.793003146 ◽

2012 ◽

Author(s):

Ian Beales

Keyword(s):

Clinical Trial ◽

Japanese Patients ◽

Peptic Ulcers ◽

Inflammatory Drug ◽

Study of helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in a tertiary care center

Medpusle International Journal of Medicine ◽

10.26611/10211239 ◽

2019 ◽

Vol 12 (3) ◽

pp. 106-109

Author(s):

Alok Misra ◽

◽

Eshan Sharma ◽

Keyword(s):

Helicobacter Pylori ◽

Care Center ◽

Tertiary Care ◽

Peptic Ulcers ◽

Tertiary Care Center ◽

Inflammatory Drug ◽

Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide

The Journal of Dermatology ◽

10.1111/j.1346-8138.2007.00244.x ◽

2007 ◽

Vol 34 (3) ◽

pp. 172-177 ◽

Cited By ~ 7

Author(s):

Naoko INOMATA ◽

Hiroyuki OSUNA ◽

Junko YAMAGUCHI ◽

Masahito ONODA ◽

Yoshihiro TAKESHITA ◽

...

Keyword(s):

Japanese Patients ◽

Cyclooxygenase 2 ◽

Inflammatory Drug ◽

Anti Inflammatory ◽

Cyclooxygenase 2 Inhibitors

THU0474 A Phase 1 Clinical Trial of ATB-346, A Gastrointestinal-Ssafe Nonsteroidal Anti-Inflammatory Drug

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.1615 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 371.3-372 ◽

Cited By ~ 3

Author(s):

J.L. Wallace

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Phase 1 Clinical Trial ◽

Inflammatory Drug ◽

Effectiveness Of Trypsin - Chymotrypsin as an Anti Inflammatory in Maxillofacial Trauma - A Double Blinded Randomised Clinical Trial

International Journal of Dentistry and Oral Science ◽

10.19070/2377-8075-21000651 ◽

2021 ◽

pp. 3196-3200

Author(s):

Muthusekhar M R ◽

Keyword(s):

Clinical Trial ◽

Maxillofacial Trauma ◽

Anti Inflammatory ◽

Double Blinded

A proof‐of‐concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug

British Journal of Pharmacology ◽

10.1111/bph.14641 ◽

2019 ◽

Vol 177 (4) ◽

pp. 769-777 ◽

Cited By ~ 20

Author(s):

John L. Wallace ◽

Peter Nagy ◽

Troy D. Feener ◽

Thibault Allain ◽

Tamás Ditrói ◽

...

Keyword(s):

Clinical Trial ◽

Hydrogen Sulfide ◽

Phase 2 ◽

Proof Of Concept ◽

Inflammatory Drug ◽

Gastrointestinal Safety ◽

Phase 2 Clinical Trial ◽

Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study

Alimentary Pharmacology & Therapeutics ◽

10.1046/j.1365-2036.1998.00434.x ◽

1998 ◽

Vol 12 (12) ◽

pp. 1201-1205 ◽

Cited By ~ 63

Author(s):

Chan ◽

Sung ◽

Suen ◽

Lee ◽

Wu ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Study ◽

Prospective Randomized Study ◽

Peptic Ulcers ◽

Inflammatory Drug ◽

Bleeding Peptic Ulcers ◽

RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer – the S.U.R.G.U.V.A.N.T. trial

BMC Cancer ◽

10.1186/s12885-018-4641-x ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 2

Author(s):

H. Paul Redmond ◽

Peter M. Neary ◽

Marcel Jinih ◽

Emer O’Connell ◽

Niamh Foley ◽

...

Keyword(s):

Clinical Trial ◽

Colon Cancer ◽

Metastatic Colon Cancer ◽

Inflammatory Agent ◽

A3 A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346)

Journal of the Canadian Association of Gastroenterology ◽

10.1093/jcag/gwz006.002 ◽

2019 ◽

Vol 2 (Supplement_2) ◽

pp. 7-8

Author(s):

J L Wallace ◽

P Nagy ◽

T Feener ◽

T Allain ◽

T Ditrói ◽

...

Keyword(s):

Clinical Trial ◽

Hydrogen Sulfide ◽

Phase 2 ◽

Proof Of Concept ◽

Inflammatory Drug ◽

Phase 2 Clinical Trial ◽